CytomX Therapeutics
This role leads clinical operations for assigned oncology studies, translating development strategies into executable study plans and ensuring quality delivery. The position involves managing and developing employees, overseeing external partners, and collaborating across multiple clinical functions to advance study start-up and enrollment. The incumbent will strengthen operational readiness for later-phase studies and improve scalable processes and vendor oversight.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
CytomX Therapeutics is a clinical-stage biopharmaceutical company focused on researching and developing innovative cancer therapies. The company pioneered Probody® therapeutics, a versatile platform designed to unlock the full potential of more potent, less toxic cancer medications, including antibody-drug conjugates (ADCs). CytomX's pipeline includes multiple Probody programs in the clinic, with a lead candidate targeting colon cancer treatment.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for CytomX Therapeutics.
Clinical Trial Manager (CTM or Sr. CTM)
Acrivon Therapeutics
Clinical Trials Manager, Early Phase Oncology (Office Based)
Gilead Sciences
Head of Clinical Operations
Borealisbio
Clinical Project Manager II - Early Phase Oncology (Sponsor Dedicated/ Remote - US) Preference for Hybrid Foster City, CA-Based Candidates
Syneos Health
Senior Clinical Trial Manager
Arbor Biotechnologies
Senior Director of Clinical Operations
Flagship Pioneering, Inc.